Regulatory approval of cancer risk-reducing (chemopreventive) drugs: Moving what we have learned into the clinic

Frank L. Meyskens, Gregory A. Curt, Dean E. Brenner, Gary Gordon, Ronald B. Herberman, Olivera Finn, Gary J. Kelloff, Samir N. Khleif, Caroline C. Sigman, Eva Szabo

Research output: Contribution to journalComment/debatepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Regulatory approval of cancer risk-reducing (chemopreventive) drugs: Moving what we have learned into the clinic'. Together they form a unique fingerprint.

Medicine & Life Sciences